What are the limitations of the flipi 2?

While the flipi 2 is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the flipi 2 to ensure safe bedside use and optimal diagnostic accuracy.

How does the flipi 2 compare to other Oncology scores?

The flipi 2 is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the flipi 2 free to use?

Yes. OpiCalc provides the flipi 2 completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

FLIPI-2

Lymphoma

Updated follicular lymphoma prognostic index using age, beta-2 microglobulin, bulk, hemoglobin, and marrow status.

Age > 60

Beta-2 microglobulin above ULN

Largest node > 6 cm

Hemoglobin < 12 g/dL

Bone marrow involvement

Calculated Interpretation

Low Risk

0 Factors

Low-risk FLIPI-2 category.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

Updated follicular lymphoma prognostic index using age, beta-2 microglobulin, bulk, hemoglobin, and marrow status.

CLINICAL INSIGHT

How it Works

Clinical Inputs

Age > 60

Beta-2 microglobulin above ULN

Largest node > 6 cm

Hemoglobin < 12 g/dL

Bone marrow involvement

CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

Updated follicular lymphoma prognostic index using age, beta-2 microglobulin, bulk, hemoglobin, and marrow status.

OpiCalc Medical Oncology ModuleLymphoma2026

CLINICAL INSIGHT

Background

Context

FLIPI-2 is included in the oncology module as a structured decision-support tool for lymphoma workflows.

No clinical reference data available.

FLIPI-2

Lymphoma

Updated follicular lymphoma prognostic index using age, beta-2 microglobulin, bulk, hemoglobin, and marrow status.

Age > 60

Beta-2 microglobulin above ULN

Largest node > 6 cm

Hemoglobin < 12 g/dL

Bone marrow involvement

Calculated Interpretation

Low Risk

0 Factors

Low-risk FLIPI-2 category.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

Updated follicular lymphoma prognostic index using age, beta-2 microglobulin, bulk, hemoglobin, and marrow status.

CLINICAL INSIGHT

How it Works

Clinical Inputs

Age > 60

Beta-2 microglobulin above ULN

Largest node > 6 cm

Hemoglobin < 12 g/dL

Bone marrow involvement

CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

Updated follicular lymphoma prognostic index using age, beta-2 microglobulin, bulk, hemoglobin, and marrow status.

OpiCalc Medical Oncology ModuleLymphoma2026

CLINICAL INSIGHT

Background

Context

FLIPI-2 is included in the oncology module as a structured decision-support tool for lymphoma workflows.

No clinical reference data available.